Workplaces in California could eventually be required to stock their first aid kits with naloxone or another medication that can stop an opioid overdose under a bill signed this week by Gov. Gavin Newsom, Los Angeles Times’ Emily Alpert Reyes reports. Naloxone, commonly sold under the brand name Narcan, can prevent someone from dying of an opioid overdose if administered promptly by a bystander. The medicine binds to the same receptors in the brain as opioids such as fentanyl, which allows the medicine to displace the opioids and reverse their effects. Of note, Emergent BioSolutions is the drug company that produces Narcan.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Amazon to stock Narcan opioid overdose reversal drug at warehouses, WSJ reports
- Emergent BioSolutions announces execution of contract options valued at $67.4M
- Emergent BioSolutions confirms $400M in orders related to smallpox, Mpox
- Study suggests waning mpox protection from Jynneos vaccine, CIDRAP reports
- Emergent BioSolutions falls -8.4%